⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NKTX News
Nkarta, Inc. Common Stock
Nkarta to Participate in September Investor Conferences
globenewswire.com
NKTX
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
globenewswire.com
NKTX
Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights
globenewswire.com
NKTX
Form 8-K
sec.gov
NKTX
Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
globenewswire.com
NKTX
Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
globenewswire.com
NKTX
A Clinical-Stage Cancer Company Is Putting AI to Work Designing Its Next Generation of Tumor-Targeting Drugs
prnewswire.com
CMPX
NKTX
GTBP
RXRX
FATE
Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
globenewswire.com
NKTX
After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
globenewswire.com
GTBP
FATE
NKTX
CMPX
CRBU
Form 8-K
sec.gov
NKTX